UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Equinix
EQIX
|
+$1.32B |
| 2 |
Digital Realty Trust
DLR
|
+$931M |
| 3 |
Western Digital
WDC
|
+$895M |
| 4 |
Simon Property Group
SPG
|
+$736M |
| 5 |
Realty Income
O
|
+$643M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$1.73B |
| 2 |
Eaton
ETN
|
+$1.21B |
| 3 |
Seagate
STX
|
+$1.1B |
| 4 |
Trane Technologies
TT
|
+$1.02B |
| 5 |
Accenture
ACN
|
+$1.01B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 40.05% |
| 2 | Financials | 11.12% |
| 3 | Healthcare | 9.54% |
| 4 | Consumer Discretionary | 9.09% |
| 5 | Communication Services | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1701
Aurinia Pharmaceuticals
AUPH
$2.14B
| $3.9M | ﹤0.01% |
229,662
-3,594
| -2% | -$57.4K |
|
1702
Klaviyo
KVYO
$5.09B
| $3.88M | ﹤0.01% |
257,260
+19,832
| +8% | +$329K |
|
|
STEL
1703
DELISTED
Stellar Bancorp
STEL
| $3.88M | ﹤0.01% |
98,749
-21,492
| -18% | -$809K |
|
1704
Payoneer
PAYO
$2.42B
| $3.88M | ﹤0.01% |
545,069
-57,741
| -10% | -$316K |
|
1705
WisdomTree Trust WisdomTree US Quality Dividend Growth Fund
DGRW
$17.2B
| $3.88M | ﹤0.01% |
40,576
-2,232
| -5% | -$211K |
|
|
ARR
1706
Armour Residential REIT
ARR
$2.3B
| $3.88M | ﹤0.01% |
222,214
+32,492
| +17% | +$559K |
|
1707
Tarsus Pharmaceuticals
TARS
$3.83B
| $3.87M | ﹤0.01% |
61,514
-1,192
| -2% | -$76.2K |
|
1708
Flowers Foods
FLO
$1.34B
| $3.87M | ﹤0.01% |
489,914
-96,189
| -16% | -$770K |
|
1709
Neogen
NEOG
$2.59B
| $3.87M | ﹤0.01% |
430,156
+70,360
| +20% | +$646K |
|
1710
DXC Technology
DXC
$1.79B
| $3.85M | ﹤0.01% |
435,205
-168,048
| -28% | -$1.74M |
|
1711
Brookfield Renewable
BEPC
$6.04B
| $3.81M | ﹤0.01% |
102,704
+45,309
| +79% | +$1.75M |
|
1712
American Superconductor
AMSC
$1.47B
| $3.79M | ﹤0.01% |
91,267
+2,881
| +3% | +$130K |
|
1713
ManpowerGroup
MAN
$2.66B
| $3.78M | ﹤0.01% |
111,900
-39,325
| -26% | -$1.2M |
|
1714
Mobileye
MBLY
$7.24B
| $3.77M | ﹤0.01% |
389,257
+50,078
| +15% | +$446K |
|
1715
HUB Group
HUBG
$2.21B
| $3.76M | ﹤0.01% |
85,896
-20,915
| -20% | -$877K |
|
1716
First Advantage
FA
$3.54B
| $3.76M | ﹤0.01% |
208,339
+5,949
| +3% | +$86.2K |
|
1717
Dimensional International Core Fixed Income ETF
DFGX
$1.77B
| $3.76M | ﹤0.01% |
70,141
| – | – |
|
1718
KB Financial Group
KB
$45.5B
| $3.76M | ﹤0.01% |
35,783
+32,190
| +896% | +$3.4M |
|
1719
Lindsay Corp
LNN
$1.25B
| $3.75M | ﹤0.01% |
30,309
-683
| -2% | -$76.4K |
|
1720
Dillards
DDS
$10.1B
| $3.75M | ﹤0.01% |
7,089
-201
| -3% | -$116K |
|
1721
Schwab Fundamental International Large Company Index ETF
FNDF
$26.4B
| $3.74M | ﹤0.01% |
70,924
-475
| -0.7% | -$25K |
|
1722
Sally Beauty Holdings
SBH
$1.51B
| $3.73M | ﹤0.01% |
264,137
+8,775
| +3% | +$118K |
|
1723
GeneDx Holdings
WGS
$2.56B
| $3.73M | ﹤0.01% |
54,336
-195,096
| -78% | -$11.1M |
|
|
SEM
1724
DELISTED
Select Medical
SEM
| $3.73M | ﹤0.01% |
225,710
-46,044
| -17% | -$759K |
|
1725
Vericel Corp
VCEL
$2B
| $3.73M | ﹤0.01% |
83,743
-16,328
| -16% | -$588K |
|
Similar funds
UBS AM's Q2 2026 Portfolio in Review
As of Q2 2026, UBS AM held 3,886 positions worth $550B, up 14% from $481B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
UBS AM's Q2 2026 filing shows 45 new, 996 increased, 1,636 reduced and 163 closed positions. Its largest new stake was Honeywell Aerospace: 1,676,062 shares worth $371M. The largest sale was Linde, an estimated $1.73B.
By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 35% a quarter earlier, followed by Financials and Healthcare.
- UBS AM's largest Q2 2026 buy was Honeywell Aerospace: 1,676,062 shares worth $371M.
- UBS AM added most to Equinix in Q2 2026, an estimated $1.32B increase.
- UBS AM's biggest Q2 2026 reduction was Linde, cutting an estimated $1.73B.
- UBS AM fully exited Hologic in Q2 2026, selling an estimated $174M.
- UBS AM's ten largest holdings make up 33% of its $550B portfolio in Q2 2026.
- UBS AM opened 45 new positions and closed 163 in Q2 2026.
- UBS AM's portfolio value rose 14% quarter-over-quarter to $550B.
Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.